vimarsana.com

Zymeworks Inc. , a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will report its first quarter 2023 financial results after... | April 17, 2023

Related Keywords

,Zymeworks Inc ,Nasdaq ,Zymeworks Inc Stock Exchange ,News ,Information ,Press Release ,Zymeworks ,Biotechnology ,Company ,Developing ,Multifunctional ,Oday ,Nnounced ,Hat ,Management ,Hill ,Report ,Its ,First ,Quarter ,023 ,Financial ,Esults Zyme Us98985y1082 ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.